Skip to main content
. 2007 Oct 17;2007(4):CD005454. doi: 10.1002/14651858.CD005454.pub2

Robinson 2004.

Methods Randomised double blind placebo controlled parallel group study, six weeks treatment
Participants 39 participants age 22 to 65 years, Amputation related pain of > 6 months. Average pain at least 2 on 11 point scale
Interventions Amitriptyline 10 mg / day up to 125 mg/day. Active placebo (benztropine 0.5 mg) dose not escalated
Outcomes Pt reported average PI on 11 pt scale. SF McGill, unmodified BPI, depression scale. Functional ability assessment, satisfaction with life
Amitriptyline was not different from placebo for phantom limb pain or residual limb pain. No sig diff in depression scores between amitriptyline and placebo
Notes Two withdrew in amitriptyline group due to AEs. Dry mouth, dizziness commonly reported
QS = 4 (R1, DB2, W1)
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Unclear risk B ‐ Unclear